US equities |
NVDA $185.35 ▼-7.39% MU $668.31 ▼-15.96% TSLA $342.39 ▼-11.11% SPCX $124.04 ▼-8.74% AMZN $261.76 ▼-1.61% AAPL $345.05 ▼-1.28% AMD $410.25 ▼-16.07% SNDK $827.17 ▼-20.27%
FinancialContent

Articles published by Progentos Therapeutics

News headline image
Progentos Therapeutics Announces First Participant Dosed in Phase 1/2a Study of PRO‑1562 for Remyelination in Multiple Sclerosis
From Progentos Therapeutics
Via Business Wire
News headline image
Progentos Therapeutics Names Paul Frohna Chief Medical Officer
From Progentos Therapeutics
Via Business Wire
News headline image
Progentos Therapeutics Appoints Andrew Miller, Ph.D. to Chairman of its Board of Directors
From Progentos Therapeutics
Via Business Wire
News headline image
Progentos Therapeutics Closes $65 Million Series A Financing to Advance Treatments for Multiple Sclerosis and Other Degenerative Diseases
From Progentos Therapeutics
Via Business Wire